{"brief_title": "Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)", "brief_summary": "This study will evaluate patients who have coronary heart disease to determine if an investigational drug will further lower cholesterol when taken in combination with an approved cholesterol lowering medication.", "detailed_description": "The duration of treatment is 10 weeks.", "condition": ["Hypercholesterolemia", "Coronary Disease"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["MK0653, ezetimibe", "Comparator: ezetimibe, placebo"], "criteria": "Inclusion Criteria: - Patients with elevated cholesterol and coronary heart disease Exclusion Criteria: - Patients who do not meet specific cholesterol levels as required by the study", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Elevated Cholesterol", "mesh_term": ["Heart Diseases", "Hypercholesterolemia", "Coronary Disease", "Coronary Artery Disease", "Myocardial Ischemia", "Ezetimibe"], "id": "NCT00092599"}